Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial
Douglas A. Jabs, Elizabeth A. Sugar, Alyce Burke, Michael M. Altaweel, Jennifer E. Thorne, Sheriza Baksh, Lyndell L. Lim, Akshay S. Thomas, Steven Yeh, Janet T. Holbrook
Topics & Concepts
MedicineAdalimumabUveitisImmunosuppressionInternal medicineMEDLINEDermatologyClinical trialInfliximabEye diseaseBiologic AgentsOcular Diseases and Behçet’s SyndromeCNS Lymphoma Diagnosis and TreatmentSarcoidosis and Beryllium Toxicity Research